Milestone Pharmaceuticals Inc.
MIST
$1.34
$0.010.75%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 184.22M | 105.96M | 82.59M | 43.42M | 55.96M |
| Total Receivables | 5.00M | 3.51M | 1.45M | 1.34M | 1.49M |
| Inventory | 1.83M | 648.00K | -- | -- | -- |
| Prepaid Expenses | 1.21M | 1.81M | 2.58M | 748.00K | 2.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 60.00K | 668.00K | 674.00K |
| Total Current Assets | 192.25M | 111.92M | 86.67M | 46.17M | 60.48M |
|
|
|||||
| Total Current Assets | 192.25M | 111.92M | 86.67M | 46.17M | 60.48M |
| Net Property, Plant & Equipment | 1.48M | 1.64M | 1.08M | 1.25M | 1.41M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 193.73M | 113.56M | 87.75M | 47.42M | 61.89M |
|
|
|||||
| Total Accounts Payable | 10.02M | 5.65M | 3.18M | 2.93M | 2.38M |
| Total Accrued Expenses | 7.87M | 6.34M | 6.86M | 5.84M | 10.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 659.00K | 647.00K | 483.00K | 515.00K | 542.00K |
| Total Finance Division Other Current Liabilities | 2.40M | 1.35M | -- | -- | -- |
| Total Other Current Liabilities | 2.40M | 1.35M | -- | -- | -- |
| Total Current Liabilities | 20.94M | 13.98M | 10.52M | 9.28M | 12.96M |
|
|
|||||
| Total Current Liabilities | 20.94M | 13.98M | 10.52M | 9.28M | 12.96M |
| Long-Term Debt | 136.30M | 57.19M | 56.21M | 55.24M | 54.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 366.00K | 539.00K | 519.00K | 641.00K | 758.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 72.00K | 83.00K | -- | -- | -- |
| Total Liabilities | 157.69M | 71.79M | 67.25M | 65.16M | 68.01M |
|
|
|||||
| Common Stock & APIC | 437.07M | 416.72M | 378.05M | 330.45M | 329.11M |
| Retained Earnings | -456.67M | -430.60M | -413.19M | -401.27M | -388.31M |
| Treasury Stock & Other | 55.65M | 55.65M | 55.65M | 53.08M | 53.08M |
| Total Common Equity | 36.05M | 41.77M | 20.50M | -17.75M | -6.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 36.05M | 41.77M | 20.50M | -17.75M | -6.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 36.05M | 41.77M | 20.50M | -17.75M | -6.12M |
|
|
|||||